Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer

Cervical cancer (CC) remains a major disease burden on the female population worldwide. Chemotherapy with cisplatin (cis-diamminedichloroplatinum (II); CDDP) and related drugs are the main treatment option for CC; however, their efficacy is limited by the development of drug resistance. Noncoding RN...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Xin, Liu, Shui, Sheng, Jiyao, Cui, Manhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Gynecology and Obstetrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263300/
https://www.ncbi.nlm.nih.gov/pubmed/32523813
http://dx.doi.org/10.7717/peerj.9234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263300/
https://www.ncbi.nlm.nih.gov/pubmed/32523813
http://dx.doi.org/10.7717/peerj.9234

Ejemplares similares